Estimate Recalculated Nov 7, 2024 04:51PM EST
Albert Cha does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIOFORM MEDICAL INC, Biodel Inc, Biohaven Pharmaceutical Holding Co Ltd., Aclaris Therapeutics, Inc., KalVista Pharmaceuticals, Inc., ProNAi Therapeutics Inc, Menlo Therapeutics Inc., and Capnia, Inc..
Albert Cha's CIK is 0001397906
2023 was Albert Cha's most active year for acquiring shares with 3 total transactions. Albert Cha's most active month to acquire stocks was the month of August. 2023 was Albert Cha's most active year for disposing of shares, totalling 3 transactions. Albert Cha's most active month to dispose stocks was the month of August. 2023 saw Albert Cha paying a total of $134,820.00 for 28,000 shares, this is the most they've acquired in one year. In 2023 Albert Cha cashed out on 36,000 shares for a total of $189,050.40, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!